Noven Pharmaceuticals Financial Market Data
| Last Close 26-Sep-2008 |
$11.80 |
Price/ Sales Ratio |
3.22 |
| 52-Week High |
$16.88 |
Price/ Book Ratio |
2.05 |
| 52-Week Low |
$8.49 |
Price/ Earnings Ratio |
-- |
| 60-Month Beta |
0.9 |
Price/ Cash Flow Ratio |
27.01 |
| Market Cap (mil.) |
$293.8 |
Return on Assets |
(16.2%) |
| Shares Outstanding (mil.) |
24.9 |
Return on Equity |
(30.2%) |
| Dividend Rate |
-- |
Current Ratio |
1.83 |
| Dividend Yield |
-- |
Long-Term Debt/Equity |
0.06 |
| # of Institutional Holders |
126 |
% Owned by Institutions |
93.0% |
| Latest Short Interest Ratio |
12.61 |
Latest Net Insider Transactions |
-- |
| Revenue Growth |
28.1% |
96.7% |
86.8% |
| EPS Growth |
0.0% |
0.0% |
0.0% |
| Dividend Growth |
0.0% |
0.0% |
0.0% |
This data is provided as per license from EDGAR Online
